Open Orphan CCO Maurice Treacy discusses the early adopters of ORPH’s Genomic Health DataBANK platform on the Vox Markets Podcast November 26, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan plc is a European-focused, rare and orphan drug consulting services platform. The Company intends to roll up a number of orphan drug services businesses. Open Orphan has two data driven digital platforms, a Genomic Health Data Platform, which is establishing a rare disease database and a Virtual Rep platform, enabling pharmaceutical companies to engage key opinion leaders and physicians. The Company is targeting rapid growth in one of the fastest growing sectors in…

Continue reading

Open Orphan’s (ORPH) Maurice Treacy Hosts Value the Markets Webinar October 24, 2019 – Posted in: Open Orphan (ORPH)

  Open Orphan, a European-focussed, rare and orphan drug consulting services platform, announces that the Company’s Chief Commercial Officer, Maurice Treacy, will be hosting a webinar alongside Value the Markets on Wednesday 30th October 2019 at 19:00 (UK time). Maurice Treacy will take the opportunity to update existing and potential shareholders on Open Orphan and will provide an insight on the Company’s Genomic Health Data platform, Europe’s first rare disease, advocacy-led genomic database. Maurice will also discuss how and why…

Continue reading